1Kim, W & Egan, JM (2008) The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 60, 470–512.
2Tolhurst, G, Heffron, H, Lam, YS, et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364–371.
3Zhou, J, Martin, RJ, Tulley, RT, et al. (2008) Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295, E1160–E1166.
4Keenan, MJ, Zhou, J, McCutcheon, KL, et al. (2006) Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 14, 1523–1534.
5Shen, L, Keenan, MJ, Martin, RJ, et al. (2009) Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity (Silver Spring) 17, 40–45.
6Robertson, MD, Currie, JM, Morgan, LM, et al. (2003) Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 46, 659–665.
7Robertson, MD, Bickerton, AS, Dennis, AL, et al. (2005) Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82, 559–567.
8Raben, A, Tagliabue, A, Christensen, NJ, et al. (1994) Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. Am J Clin Nutr 60, 544–551.
9Johnston, KL, Thomas, EL, Bell, JD, et al. (2010) Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med 27, 391–397.
10Maki, KC, Pelkman, CL, Finocchiaro, ET, et al. (2012) Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. J Nutr 142, 717–723.
11Bodinham, CL, Smith, L, Wright, J, et al. (2012) Dietary fibre improves first-phase insulin secretion in overweight individuals. PLoS One 7, e40834.
12Bodinham, CL, Frost, GS & Robertson, MD (2010) Acute ingestion of resistant starch reduces food intake in healthy adults. Br J Nutr 103, 917–922.
13Willis, HJ, Eldridge, AL, Beiseigel, J, et al. (2009) Greater satiety response with resistant starch and corn bran in human subjects. Nutr Res 29, 100–105.
14Liljeberg, HG, Akerberg, AK & Bjorck, IM (1999) Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am J Clin Nutr 69, 647–655.
15Nilsson, AC, Ostman, EM, Holst, JJ, et al. (2008) Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 138, 732–739.
16Zhou, J, Hegsted, M, McCutcheon, KL, et al. (2006) Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring) 14, 683–689.
17Freeland, KR, Wilson, C & Wolever, TM (2010) Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103, 82–90.
18Adam, TC & Westerterp-Plantenga, MS (2005) Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. Br J Nutr 93, 845–851.
19Tarini, J & Wolever, TM (2010) The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35, 9–16.
20Barone Lumaga, R, Azzali, D, Fogliano, V, et al. (2012) Sugar and dietary fibre composition influence, by different hormonal response, the satiating capacity of a fruit-based and a beta-glucan-enriched beverage. Food Funct 3, 67–75.
21Frost, GS, Brynes, AE, Dhillo, WS, et al. (2003) The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur J Clin Nutr 57, 293–298.
22Klosterbuer, A, Greaves, K & Slavin, J (2012) Fiber intake inconsistently alters gut hormone levels in humans following acute or chronic intake. J Food Res 1, 255–273.
23Robertson, MD (2012) Dietary-resistant starch and glucose metabolism. Curr Opin Clin Nutr Metab Care 15, 362–367.
24Flint, A, Raben, A, Ersboll, AK, et al. (2001) The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 25, 781–792.
25Verdich, C, Toubro, S, Buemann, B, et al. (2001) The role of postprandial releases of insulin and incretin hormones in meal-induced satiety – effect of obesity and weight reduction. Int J Obes Relat Metab Disord 25, 1206–1214.
26Elahi, D, Egan, JM, Shannon, RP, et al. (2008) GLP-1 (9–36) amide, cleavage product of GLP-1 (7–36) amide, is a glucoregulatory peptide. Obesity (Silver Spring) 16, 1501–1509.
27Meier, JJ, Gethmann, A, Nauck, MA, et al. (2006) The glucagon-like peptide-1 metabolite GLP-1-(9–36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans. Am J Physiol Endocrinol Metab 290, E1118–E1123.